← Back to Search

Continuous Glucose Monitor

Continuous Glucose Monitor Application for Diabetes

Phase < 1
Waitlist Available
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative days 1-5
Awards & highlights

Study Summary

This trialwill compare two methods of glucose monitoring in post-op kidney transplant patients to see which works better.

Eligible Conditions
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative days 1-5
This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative days 1-5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average Daily Glucose
Secondary outcome measures
Number of Hyperglycemic Episodes
Number of Hypoglycemic Episodes
Total Insulin Use

Side effects data

From 2016 Phase 4 trial • 85 Patients • NCT01970241
21%
Hypoglycemia
100%
80%
60%
40%
20%
0%
Study treatment Arm
NPH With Corticosteroid
Control

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention ArmExperimental Treatment3 Interventions
Group II: Control ArmPlacebo Group3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Finger Stick Glucose Measurement
2020
Completed Early Phase 1
~40
Insulin
2000
Completed Phase 4
~4280
Continuous Glucose Monitor Application
2020
Completed Early Phase 1
~40

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
458 Previous Clinical Trials
470,893 Total Patients Enrolled
5 Trials studying Diabetes
247 Patients Enrolled for Diabetes

Media Library

Continuous Glucose Monitor Application (Continuous Glucose Monitor) Clinical Trial Eligibility Overview. Trial Name: NCT04742023 — Phase < 1
Diabetes Research Study Groups: Intervention Arm, Control Arm
Diabetes Clinical Trial 2023: Continuous Glucose Monitor Application Highlights & Side Effects. Trial Name: NCT04742023 — Phase < 1
Continuous Glucose Monitor Application (Continuous Glucose Monitor) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04742023 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation
2020. "Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04742023.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top